| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman, President &CEO | Director
3 companies
Mahoney Michael F serves as a Chairman, President &CEO at BSX and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 3 buys and 26 sells. Those positions are worth an estimated $1.5M at current prices.
Historically, Mahoney Michael F's trades have earned a middling insider score of 57/100 across 20 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -6.9%.
The biggest single holding is BSX (~$1.1M) as Chairman, President &CEO. The recent filings there lean toward selling, a net 3,064,113 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | BSX Boston Scientific Corporation | Chairman, President &CEO | Buy | 186,240 | $48.33 | $9,001,407.55 | +13.3% | - | - | |
| Feb 2, 2026 | BSX Boston Scientific Corporation | Chairman, President &CEO | Sale+OE | 160,901 | $93.49 | $15,043,394.38 | -10.2% | - | - | |
| Jun 2, 2025 | BSX Boston Scientific Corp | Chairman, President &CEO | Sale+OE | 164,443 | $103.69 | $17,051,135.67 | -10.0% | +2.4% | -54.2% | |
| May 1, 2025 | BSX Boston Scientific Corp | Chairman, President &CEO | Sale+OE | 164,443 | $102.48 | $16,851,973.70 | -9.7% | +3.5% | -45.2% | |
| Apr 1, 2025 | BSX Boston Scientific Corp | Chairman, President &CEO | Sale+OE | 164,442 | $100.01 | $16,445,071.54 | -9.3% | +6.1% | -38.8% | |
| Feb 18, 2025 | CVS Cvs Health Corp | Director | Buy | 30,000 | $66.70 | $2,001,000.00 | +320.6% | -4.3% | +18.6% | |
| Nov 5, 2024 | BSX Boston Scientific Corp | Chairman, President &CEO | Sale+OE | 162,778 | $84.75 | $13,794,850.92 | -9.7% | +20.5% | +15.6% | |
| Oct 7, 2024 | BSX Boston Scientific Corp | Chairman, President &CEO | Sale+OE | 162,777 | $84.63 | $13,775,791.62 | -9.4% | +8.2% | +13.6% | |
| Sep 5, 2024 | BSX Boston Scientific Corp | Chairman, President &CEO | Sale+OE | 162,777 | $81.17 | $13,212,543.98 | -9.1% | +11.6% | +31.8% | |
| May 2, 2024 | CVS Cvs Health Corp | Director | Buy | 9,181 | $54.49 | $500,293.81 | +5,246% | +9.4% | +22.3% |